ANTIPHOSPHOLIPID ANTIBODIES IN WOMEN WITH PLACENTAL INSUFFICIENCY

Authors

  • G.A. Safarova Azerbaijan State Advanced Training Institute for Doctors named after A. Aliyev
  • L.M. Rzaguliyeva Azerbaijan State Advanced Training Institute for Doctors named after A. Aliyev

DOI:

https://doi.org/10.34921/amj.2022.2.013

Keywords:

antiphospholipid antibodies, placental insufficiency, enzyme immunoassay

Abstract

The article presents the results of studying the presence of various antiphospholipid antibodies and their frequency in women with placental insufficiency. The study involved 83 women with singleton pregnancies (average age 29.9 ± 3.06 years), who were divided into 2 groups: the main group - 58 pregnant women with placental insufficiency; control group – 25 pregnant women without placental insufficiency. The presence of antiphospholipid antibodies was determined using immunometric tests and a functional coagulation test for lupus anticoagulant. In patients with placental insufficiency, a positive result of lupus anticoagulant was detected in 73.1% of cases, antibodies to cardiolipin - 46.2%, and antibodies to β2-glycoprotein I in 15.4% of cases. This study confirms the high prevalence of antiphospholipid antibodies in women with placental insufficiency. Testing in this high-risk group can improve fetal, maternal and newborn outcomes and may lead to better outcomes in future pregnancies.

Downloads

Download data is not yet available.

Published

2022-06-30

How to Cite

Safarova , G., & Rzaguliyeva , L. (2022). ANTIPHOSPHOLIPID ANTIBODIES IN WOMEN WITH PLACENTAL INSUFFICIENCY. Azerbaijan Medical Journal, (2), 84–88. https://doi.org/10.34921/amj.2022.2.013

Issue

Section

CLINICAL RESEARCH